Perry Elliott

Perry Elliott

University College London

H-index: 128

Europe-United Kingdom

About Perry Elliott

Perry Elliott, With an exceptional h-index of 128 and a recent h-index of 90 (since 2020), a distinguished researcher at University College London, specializes in the field of Cardiomyopathy, heart failure, genetics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and …

Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’[International Journal of Cardiology, 2023, 41 …

Management of arrhythmogenic right ventricular cardiomyopathy

Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

Electrocardiographic abnormalities in patients with cardiomyopathies

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme …

Perry Elliott Information

University

Position

Professor of Cardiovascular Medicine Barts Heart Centre St Bartholomew

Citations(all)

125805

Citations(since 2020)

64236

Cited By

87645

hIndex(all)

128

hIndex(since 2020)

90

i10Index(all)

398

i10Index(since 2020)

321

Email

University Profile Page

Google Scholar

Perry Elliott Skills & Research Interests

Cardiomyopathy

heart failure

genetics

Top articles of Perry Elliott

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and …

European Heart Journal

2024/3/1

Corrigendum to ‘Syncope in hypertrophic cardiomyopathy (part II): An expert consensus statement on the diagnosis and management’[International Journal of Cardiology, 2023, 41 …

International Journal of Cardiology

2024/2/15

Management of arrhythmogenic right ventricular cardiomyopathy

2024/2/1

Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy

2024/1/30

Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial

JAMA cardiology

2024/1/1

Perry Elliott
Perry Elliott

H-Index: 81

Electrocardiographic abnormalities in patients with cardiomyopathies

The American journal of emergency medicine

2014/6/1

Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease

Heart

2024/4/30

Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme …

European heart journal

2024/4/10

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis: A Systematic Review and Meta-Analysis

Circulation: Genomic and Precision Medicine

2022/6

Руководство ESC 2023 года по ведению пациентов с кардиомиопатиями

Атеросклероз

2024/3/15

Identification of novel genetic variants associated with feline cardiomyopathy using targeted next-generation sequencing

Human genetics

2020/11

Gene therapy composition and treatment of right ventricular arrhythmogenic cardiomyopathy

2024/2/8

The diagnostic and therapeutic implications of phenocopies and mimics of Hypertrophic Cardiomyopathy

2024/3/4

Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block

Open Heart

2024/3/1

2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)

2023/10/1

Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants

Circulation: Genomic and Precision Medicine

2023/10

Response by Elliott et al to Letter Regarding Article: Effects of Tafamidis on Heart Failure Hospitalization: The Tale of The Dog That Did Not Bark.

European Journal of Heart Failure

2023/9/28

A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making

European Heart Journal-Quality of Care and Clinical Outcomes

2023/9/2

Structure determination and analysis of titin A-band fibronectin type III domains provides insights for disease-linked variants and protein oligomerisation

Journal of Structural Biology

2023/9/1

Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine

2023/8

See List of Professors in Perry Elliott University(University College London)

Co-Authors

academic-engine